This article reviews recent systems-level studies that provide fundamental new insights into how repetitive activation of innate signaling pathways produce epigenetic ‘training’ to induce adaptive epithelial responses and presents studies demonstrating efficacy of these in reducing airway inflammation in preclinical models
This review summarizes the rationale for the use of biologics in eosinophilic diseases and their mechanisms of action.
Keywords: allergic airway disease, allergic rhinitis, asthma, biologics, children, chronic rhinosinusitis, immunotherapy. Citation: Giallongo A, Parisi GF, Licari A, Pulvirenti G, Cuppari C, Salpietro C, Marseglia GL, Leonardia S. Novel therapeutic targets for allergic airway disease in children. Drugs in
This article summarizes the current status and ongoing clinical trials incorporating immunotherapy into the management of inoperable stage III nonsmall cell lung cancer.
The aim of this article is to provide an overview of the scientific literature on Easyhaler, with the purpose of emphasising features that make it close to the concept of an ‘ideal’ inhaler for daily use in patients with asthma or chronic obstructive pulmonary disease.
